Lung adenocarcinoma is a type of lung cancer and belongs to non-small cell carcinoma.
North America dominates the global lung cancer surgery market. Growth in the North American segment is primarily driven by the rapid growth in the aging population, availability of reimbursement for lung cancer surgeries, and increasing incidence of lung cancer.

The global Lung Cancer Surgery market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Lung Cancer Surgery volume and value at global level, regional level and company level. From a global perspective, this report represents overall Lung Cancer Surgery market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Lung Cancer Surgery in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Lung Cancer Surgery manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Accuray
Angiodynamics
Ethicon
Intuitive Surgical
Olympus
Teleflex
Ackermann Instrumente
Karl Storz
Scanlan International
Trokamed

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Surgical Instruments
Monitoring And Visualization System

Segment by Application
Lobectomy
Removal Of Sleeve
Regional Excision
Lung Removed All
Minimally Invasive Surgery